ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: communication

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  June 1, 2014

Legislative news on biosimilars, safety warning on epidural corticosteroid injections, and other drug updates rheumatologists need to know

Filed under:Biologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisResearch Rheum Tagged with:anti-inflammatoryBiologicsBiosimilarscelecoxib (Elyxyb)corticosteroid psychosisMethotrexatepsoriatic arthritisradiographraloxifeneResearchrituximabSafety

Update on Healthcare Reform in 2014 under the Affordable Care Act

Joseph Flood, MD, & Kam Nola, PharmD, MS  |  June 1, 2014

The American College of Rheumatology continues to monitor healthcare system changes under the ACA; educate rheumatologists, rheumatology health professionals

Filed under:Legislation & AdvocacyPractice SupportPresident's PerspectiveProfessional TopicsQuality Assurance/Improvement Tagged with:AC&RACAAdvocacyAffordable Care Act (ACA)American College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)BiosimilarsFloodLegislationMedicarePQRSPractice Management

Ethics Forum: The Challenge of Multidisciplinary Care in Rheumatology

Kirk D. Jenkins, MD; Robert H. Shmerling, MD; Rebecca B. Yarrison, PhD; and Kristine M. Lohr, MD, MS  |  May 1, 2014

A patient with autoimmune ocular disease raises concerns about the moral, professional obligations of rheumatologists to help patients whose condition is not clearly within the scope of rheumatology

Filed under:EthicsPractice SupportProfessional TopicsWorkforce Tagged with:drugEthicsmultidisciplinary carepatient carePractice ManagementprednisonerheumatologistrheumatologySteroids

U.S. Bone and Joint Initiative Summit Examines Quality of Patient-Centered Musculoskeletal Care

Kurt Ullman  |  May 1, 2014

Physicians discuss definition, implementation of best clinical practices for patient care at multidisciplinary meeting last November

Filed under:ConditionsOsteoarthritis and Bone DisordersPractice SupportQuality Assurance/Improvement Tagged with:best practicesMusculoskeletalOsteoarthritisOsteoporosisPainpatient carePractice ManagementQualityrheumatologist

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  April 2, 2014

Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone DisordersRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:BiologicsdrugDrug SafetyMethotrexateOsteoporosisRheumatoid arthritisrheumatologySafetySystemic lupus erythematosus

Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

By regulating molecules key to osteoclast/osteoblast processes, methotrexate may reduce bone destruction in inflammatory arthritis, osteolysis, especially in combination with adenosine

Filed under:ConditionsDrug UpdatesMeeting ReportsOsteoarthritis and Bone DisordersOther Rheumatic ConditionsRheumatoid Arthritis Tagged with:ACR/ARHPAdenosineanti-inflammatorybonedrugMethotrexateOsteoarthritispatient careRheumatoid arthritisrheumatologist

Registered Nurses Can Help Guide Rheumatology Patients Through Clinical Trials

Tara L. Barker, RN, BSN, MSN  |  March 1, 2014

How RN research coordinators can prevent deviations, interruptions in rheumatology clinical trials and enhance patient care

Filed under:From the CollegePractice SupportResearch RheumWorkforce Tagged with:clinical trialsimagingpatient carePractice Managementregistered nurseResearchresearch coordinatorrheumatologistrheumatology

ACR’s Lupus Initiative Advances Education Around Diagnosing, Treating Disease

Joseph Flood, MD  |  March 1, 2014

Online progam boasts continuing medical education, learning curriculum for healthcare professionals and students, as well as a smartphone app to help patients track their symptoms

Filed under:Career DevelopmentConditionsEducation & TrainingLegislation & AdvocacyPresident's PerspectiveProfessional TopicsSystemic Lupus Erythematosus Tagged with:AC&RACR Lupus InitiativeAdvocacyAmerican College of Rheumatology (ACR)continuing medical educationeducation and trainingLupuspatient carerheumatologistSystemic lupus erythematosus

Tech Talk: Smartphone Apps, Online Games May Encourage Healthy Behaviors in Rheumatology Patients

Susan Bernstein  |  February 1, 2014

Customized text messages and virtual reality technology can help health professionals prompt patients to take medications and get exercise

Filed under:AppsConditionsResearch RheumRheumatoid ArthritisSystemic Lupus ErythematosusTechnology Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)appspatient carepatient communicationResearchRheumatoid arthritisrheumatologistrheumatologySmartphone appSystemic lupus erythematosusTechnologyvirtual reality

2013 ACR/ARHP Annual Meeting: Health Professionals In the Spotlight

Richard Quinn  |  January 1, 2014

ARHP members are honored with awards for research, education, advocacy, and patient care in rheumatology

Filed under:Legislation & AdvocacyMeeting ReportsProfessional TopicsProfiles Tagged with:ACR/ARHP Annual MeetingAdvocacyAssociation of Rheumatology Professionals (ARP)Awardsdrughealth professionalsPediatricsProfilerheumatologist

  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 97
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences